Skip to main content
SpringerLink
Log in

Welchen Stellenwert hat Telaprevir bei der Hepatits-C-Virus-Infektion?

  • Für Sie gelesen
  • Published:
Der Gastroenterologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Farnik H, Mihm U, Zeuzem S (2009) Optimal therapy in genotype 1 patients. Liver Int 29 (Suppl 1): 23–30

    Article  PubMed  Google Scholar 

  2. Hézode C, Forestier N, Dusheiko G et al (2009) Telaprevir and Peginterferon with or without Ribavirin for chronic HCV infection. PROVE2 Study. NEJM 360: 1839–1850

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der Autor gibt an, dass kein Interessenskonflikt besteht.

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin II, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106, Freiburg, Deutschland

    N. Semmo

Authors
  1. N. Semmo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Semmo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Semmo, N. Welchen Stellenwert hat Telaprevir bei der Hepatits-C-Virus-Infektion?. Gastroenterologe 4, 450–451 (2009). https://doi.org/10.1007/s11377-009-0353-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11377-009-0353-8

Search

Navigation